Evidence map›Paper›PMID 37987640›Full record

ArticleThe Journal of international medical research2023

FKBP5 associated CD8 T cell infiltration is a novel prognostic biomarker in luminal B breast cancer.

Fei Tong, Genlin Lu, Jie Zang, Dingji Hao, Wangjue Xu, Jida Chen, Qiong Ding, Hanchu Xiong

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Fei TongDepartment of General Surgery, The People's Hospital of Long you County, Quzhou, Zhejiang Province, China.ORCID 0000-0003-1013-6385
Genlin LuDepartment of General Surgery, The People's Hospital of Long you County, Quzhou, Zhejiang Province, China.
Jie ZangDepartment of General Surgery, Zhejiang Putuo Hospital, Zhoushan, Zhejiang Province, China.
Dingji HaoDepartment of Thyroid Breast Hernia Surgery, Tonglu County Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang Province, China.
Wangjue XuDepartment of General Surgery, The People's Hospital of Long you County, Quzhou, Zhejiang Province, China.
Jida ChenDepartment of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Qiong DingDepartment of General Surgery, Zhejiang Putuo Hospital, Zhoushan, Zhejiang Province, China.
Hanchu XiongCancer Centre, Department of Radiation Oncology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.ORCID 0000-0001-6075-6895
Quzhou City People's Hospital · CNCentral Hospital of Putuo District · CNHangzhou Hospital of Traditional Chinese Medicine · CNSir Run Run Shaw Hospital · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the relationship between FKBP prolyl isomerase 5 (

methodsThe Gene Expression Profiling Interactive Analysis 2, Human Protein Atlas and breast cancer gene-expression miner v4.5 databases were used for data mining and analysing

resultsUpregulated

conclusionThese findings suggest that

Indexed as

Breast NeoplasmsCD3 ComplexCD8-Positive T-LymphocytesComputational BiologyFemaleHumansPrognosisTacrolimus Binding Protein 5CD3 ComplexTacrolimus Binding Protein 5bioinformaticsbreast cancerCD8 T cellsFKBP5

Identifiers

PMID37987640
PMCPMC10664447
OpenAlexW4388869851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.